Brief: Cerevel Therapeutics To Present At 41St Annual J.P. Morgan Healthcare Conference And Provide Pipeline Update
Jan 9 (Reuters) - Cerevel Therapeutics Holdings Inc
CERE.O :
* CEREVEL THERAPEUTICS TO PRESENT AT 41ST ANNUAL J.P. MORGAN
HEALTHCARE CONFERENCE AND PROVIDE PIPELINE UPDATE
* CEREVEL THERAPEUTICS HOLDINGS INC - PHASE 2
PROOF-OF-CONCEPT
DARIGABAT PANIC DISORDER TRIAL TO BE INITIATED IN Q2 2023
* CEREVEL THERAPEUTICS - MULTIPLE DATA READOUTS & CASH
RUNWAY INTO
2025 TO SUPPORT ADVANCEMENT OF DIVERSE PIPELINE OF NOVEL
NEUROSCIENCE DRUG CANDIDATES
Source text for Eikon: ID:nGNX4hSHyB
Further company coverage: CERE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cerevel Therapeutics Holdings
See all newsBrief: Abbvie Reaffirms FY Adj Diluted EPS Guidance Range $10.71-$10.91
Cerevel Therapeutics Holdings Inc expected to post a loss of 61 cents a share - Earnings Preview
Cerevel Therapeutics Holdings Inc expected to post a loss of 62 cents a share - Earnings Preview
Cerevel Therapeutics Holdings Inc expected to post a loss of 61 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Ally Financial, Zscaler, Las Vegas Sands